HealthDay: Is new clot-busting medication better treatment for stroke?
UC expert says encouraging early findings need further study
Researchers are studying if a new "clot-busting" drug might be safer than the current treatment for strokes caused by brain bleeds.
The drug, tenecteplase, is currently approved for treating heart attacks but has not received FDA approval as a stroke treatment.
Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, told HealthDay the new drug is easier to administer and is less costly than current standard treatments. However, early results showing its effectiveness in patient case studies need to be replicated in formalized clinical trials.
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
Related Stories
From Intern to Full-Time: Recent Lighting Design grad joins...
July 16, 2024
Lighting & Sound America spotlights recent graduate Riley Rowan's new position at Bandit Lites, a full-service design, management and producer of live events and entertainment.
CCM alum Donald Lawrence to be inducted into Cincinnati Black...
July 16, 2024
UC College-Conservatory of Music alumnus Donald Lawrence is part of the 2024 class of Cincinnati Black Music Walk of Fame inductees. Located at the Banks in downtown Cincinnati, the induction ceremony on July 27 will feature a parade of stars and a free concert by the Zapp Band.
U.S. stroke survival is improving, but race still plays role
July 16, 2024
U.S. News & World Report, HealthDay and Real Health covered new research from the University of Cincinnati that found overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals.